Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307 Jul 26, 2018 Life Science
I-Mab Out-Licenses Bi-Specific to South Korea’s ABL Bio in $100 Million Deal Jul 26, 2018 Life Science
KEYTRUDA® (pembrolizumab) is the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma Jul 26, 2018 Life Science
GlaxoSmithKline strikes $300 million deal with 23andMe for genetics-driven drug research Jul 25, 2018 Life Science
Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory Jul 25, 2018 Life Science
Hillhouse Capital Leads $230M Series B Preferred Stock Financing In US Biopharmaceutical Firm Gossamer Bio Jul 24, 2018 Life Science
Pfizer Plans $465 Million Project in Michigan, Part of its $5 Billion Manufacturing Plan Jul 24, 2018 Life Science
